|
Cellomics Launches new HCS solutions for Oncology |
|
|
Pittsburgh, Pennsylvania, USA, and Geneva, Switzerland- September 12, 2005- Cellomics, Inc. announced the launch of their latest BioApplication, Tube Formation, at the 11th Annual Society for Biomolecular Screening (SBS) conference in Geneva, Switzerland. The Tube Formation BioApplication is an image analysis algorithm that allows scientists to quantitatively analyze angiogenic tube formation in vitro. Angiogenesis is a critical process in cancer as well as normal physiological processes, so the ability to rapidly measure the degree of angiogenic tube formation will help to accelerate drug-discovery and medical-research efforts in many areas. The Tube Formation BioApplication is a validated high-content assay that measures the morphology of endothelial cells and tubes, thus providing a direct measure of angiogenesis in a functional assay. The Tube Formation BioApplication will be available in Q4 2005 for all versions of the ArrayScan HCS Reader as well as the KineticScan HCS Reader.
About Cellomics
Cellomics, a brand of the Fisher Biosciences group, provides complete systems for High Content Screening (HCS) and Analysis (HCA) to drug discovery and systems biology researchers. The Cellomics platform includes automated imaging instrumentation (ArrayScan® and KineticScan® HCS Readers), BioApplication image analysis software, High Content Informatics (HCi™), and HitKit® fluorescent reagent kits, fully integrated to improve the quality and productivity of cell-based assays. Cellomics’ proprietary platforms are in use at multiple sites within the top 15 pharmaceutical companies, as well as leading biotechnology companies and academic centers throughout the world. For more information about Cellomics-brand products and services, please visit www.cellomics.com or call 412-770-2200.
About Fisher Biosciences
Fisher Biosciences, a unit of Fisher Scientific International Inc., manufactures and supplies a wide range of products and services across the general-chemistry and life-sciences arenas. From fine and high-purity chemicals, clinical diagnostics, proprietary protein-research and cell-culture products, and sterile-liquid-handling systems, to innovative RNA-interference technology, Fisher Biosciences serves scientific-research, healthcare, drug-discovery, and general-industrial customers around the world.
|
|
Last Updated ( Thursday, 06 July 2006 )
|
Home 
Cellomics Launches new HCS solutions for Oncology
top